• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于心脏淀粉样变性患者心脏磁共振瘢痕特征分析的新方法:一项初步研究。

A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study.

作者信息

Alfieri Michele, Guerra Federico, Lofiego Carla, Fogante Marco, Ciliberti Giuseppe, Vagnarelli Fabio, Barbarossa Alessandro, Principi Samuele, Stronati Giulia, Volpato Giovanni, Compagnucci Paolo, Valeri Yari, Tofoni Paolo, Brugiatelli Leonardo, Capodaglio Irene, Esposto Pirani Paolo, Argalia Giulio, Schicchi Nicolò, Messano Loredana, Centanni Maurizio, Giovagnoni Andrea, Perna Gian Piero, Dello Russo Antonio, Casella Michela

机构信息

Cardiology and Arrhythmology Clinic, University Hospital "Azienda Ospedaliero-Universitaria delle Marche", Via Conca 71, 60126 Ancona, Italy.

Department of Biomedical Sciences and Public Health, Marche Polytechnic University, 60121 Ancona, Italy.

出版信息

Medicina (Kaunas). 2024 Apr 8;60(4):613. doi: 10.3390/medicina60040613.

DOI:10.3390/medicina60040613
PMID:38674259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11051713/
Abstract

: Cardiac magnetic resonance (CMR) imaging has become an essential instrument in the study of cardiomyopathies; it has recently been integrated into the diagnostic workflow for cardiac amyloidosis (CA) with remarkable results. An additional emerging role is the stratification of the arrhythmogenic risk by scar analysis and the possibility of merging these data with electro-anatomical maps. This is made possible by using a software (ADAS 3D, Galgo Medical, Barcelona, Spain) able to provide 3D heart models by detecting fibrosis along the whole thickness of the myocardial walls. Little is known regarding the applications of this software in the wide spectrum of cardiomyopathies and the potential benefits have yet to be discovered. In this study, we tried to apply the ADAS 3D in the context of CA. : This study was a retrospectively analysis of consecutive CMR imaging of patients affected by CA that were treated in our center (Marche University Hospital). Wherever possible, the data were processed with the ADAS 3D software and analyzed for a correlation between the morphometric parameters and follow-up events. The outcome was a composite of all-cause mortality, unplanned cardiovascular hospitalizations, sustained ventricular arrhythmias (VAs), permanent reduction in left ventricular ejection fraction, and pacemaker implantation. The secondary outcomes were the need for a pacemaker implantation and sustained VAs. : A total of 14 patients were deemed eligible for the software analysis: 8 patients with wild type transthyretin CA, 5 with light chain CA, and 1 with transthyretin hereditary CA. The vast majority of imaging features was not related to the composite outcome, but atrial wall thickening displayed a significant association with both the primary ( = 0.003) and the secondary outcome of pacemaker implantation ( = 0.003). The software was able to differentiate between core zones and border zones of scars, with the latter being the most extensively represented in all patients. Interestingly, in a huge percentage of CMR images, the software identified the highest degree of core zone fibrosis among the epicardial layers and, in those patients, we found a higher incidence of the primary outcome, without reaching statistical significance ( = 0.18). Channels were found in the scar zones in a substantial percentage of patients without a clear correlation with follow-up events. : CMR imaging plays a pivotal role in cardiovascular diagnostics. Our analysis shows the feasibility and applicability of such instrument for all types of CA. We could not only differentiate between different layers of scars, but we were also able to identify the presence of fibrosis channels among the different scar zones. None of the data derived from the ADAS 3D software seemed to be related to cardiac events in the follow-up, but this might be imputable to the restricted number of patients enrolled in the study.

摘要

心脏磁共振成像(CMR)已成为心肌病研究中的重要工具;最近它已被纳入心脏淀粉样变性(CA)的诊断流程,并取得了显著成果。另一个新出现的作用是通过瘢痕分析对心律失常风险进行分层,以及将这些数据与电解剖图合并的可能性。这可以通过使用一款软件(ADAS 3D,Galgo Medical,西班牙巴塞罗那)来实现,该软件能够通过检测心肌壁全层的纤维化来提供三维心脏模型。关于该软件在广泛的心肌病中的应用知之甚少,其潜在益处还有待发现。在本研究中,我们试图在CA的背景下应用ADAS 3D。

本研究是对在我们中心(马尔凯大学医院)接受治疗的CA患者的连续CMR成像进行的回顾性分析。只要有可能,就使用ADAS 3D软件处理数据,并分析形态学参数与随访事件之间的相关性。结局是全因死亡率、非计划心血管住院、持续性室性心律失常(VAs)、左心室射血分数永久性降低以及起搏器植入的综合结果。次要结局是起搏器植入的必要性和持续性VAs。

共有14名患者被认为符合软件分析条件:8名野生型转甲状腺素蛋白CA患者、5名轻链CA患者和1名转甲状腺素蛋白遗传性CA患者。绝大多数影像学特征与综合结局无关,但心房壁增厚与起搏器植入的主要结局(P = 0.003)和次要结局(P = 0.003)均显示出显著相关性。该软件能够区分瘢痕的核心区和边缘区,后者在所有患者中占比最大。有趣的是,在很大比例的CMR图像中,该软件在心肌外层中识别出最高程度的核心区纤维化,并且在这些患者中,我们发现主要结局的发生率较高,但未达到统计学显著性(P = 0.18)。在相当比例的患者的瘢痕区发现了通道,但与随访事件无明显相关性。

CMR成像在心血管诊断中起着关键作用。我们的分析表明了这种仪器对所有类型CA的可行性和适用性。我们不仅能够区分瘢痕的不同层,还能够识别不同瘢痕区中纤维化通道的存在。从ADAS 3D软件得出的数据似乎均与随访中的心脏事件无关,但这可能归因于本研究纳入的患者数量有限。

相似文献

1
A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study.一种用于心脏淀粉样变性患者心脏磁共振瘢痕特征分析的新方法:一项初步研究。
Medicina (Kaunas). 2024 Apr 8;60(4):613. doi: 10.3390/medicina60040613.
2
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.心脏淀粉样变性及其模仿疾病患者中CMR测量的纵向应变模式及其与延迟钆增强的关联。
J Cardiovasc Magn Reson. 2017 Aug 7;19(1):61. doi: 10.1186/s12968-017-0376-0.
3
Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.采用心血管磁共振弥散张量成像技术对淀粉样变患者的心脏受累情况进行特征分析。
J Cardiovasc Magn Reson. 2019 Sep 5;21(1):56. doi: 10.1186/s12968-019-0563-2.
4
Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.心脏磁共振成像组织图谱对心脏淀粉样变性预后的评估:一项系统综述和荟萃分析
Int J Cardiol. 2024 May 15;403:131892. doi: 10.1016/j.ijcard.2024.131892. Epub 2024 Feb 19.
5
Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.利用心脏磁共振典型的延迟钆增强模式和轻链进行转甲状腺素蛋白心脏淀粉样变性的无创诊断。
Eur Heart J Cardiovasc Imaging. 2023 May 31;24(6):829-837. doi: 10.1093/ehjci/jeac249.
6
Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow.迈向心脏淀粉样变性诊断:焦磷酸盐锝 99m 核素平面显像的单中心经验及诊断工作流程标准化的机遇。
Medicina (Kaunas). 2023 Feb 16;59(2):378. doi: 10.3390/medicina59020378.
7
Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.心脏轻链型淀粉样变的局部心肌微血管功能障碍:3T心血管磁共振评估
J Cardiovasc Magn Reson. 2016 Apr 6;18:16. doi: 10.1186/s12968-016-0240-7.
8
Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.心脏再同步治疗患者的瘢痕特征预测危及生命的心律失常事件和心源性猝死:GAUDI-CRT 研究。
JACC Cardiovasc Imaging. 2018 Apr;11(4):561-572. doi: 10.1016/j.jcmg.2017.04.021. Epub 2017 Aug 2.
9
Light-Chain Cardiac Amyloidosis: Cardiac Magnetic Resonance for Assessing Response to Chemotherapy.轻链心脏淀粉样变:评估化疗反应的心脏磁共振成像。
Korean J Radiol. 2024 May;25(5):426-437. doi: 10.3348/kjr.2023.0985.
10
Myocardial Edema and Prognosis in Amyloidosis.心肌水肿与淀粉样变的预后。
J Am Coll Cardiol. 2018 Jun 26;71(25):2919-2931. doi: 10.1016/j.jacc.2018.03.536.

本文引用的文献

1
Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis.
Can J Cardiol. 2024 Mar;40(3):372-384. doi: 10.1016/j.cjca.2023.10.022. Epub 2023 Nov 3.
2
Post-ablation cardiac magnetic resonance in ventricular tachycardia ablation: shining light on dark cores and corridors.室性心动过速消融术后的心脏磁共振成像:照亮隐匿瘢痕及通道。
Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):199-200. doi: 10.1093/ehjci/jead275.
3
Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis.心脏磁共振成像对心脏淀粉样变性的预后预测:一项荟萃分析的系统评价
Eur Heart J Open. 2023 Sep 22;3(5):oead092. doi: 10.1093/ehjopen/oead092. eCollection 2023 Sep.
4
Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study).消融后心脏磁共振评估室性心动过速复发(PAM-VT 研究)。
Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):188-198. doi: 10.1093/ehjci/jead261.
5
Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices.心脏淀粉样变性患者的心律失常:临床管理与器械的综合综述
J Cardiovasc Dev Dis. 2023 Aug 5;10(8):337. doi: 10.3390/jcdd10080337.
6
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
7
The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis.多参数心脏磁共振成像对系统性轻链淀粉样变性患者的预后价值
Front Oncol. 2023 May 3;13:1069788. doi: 10.3389/fonc.2023.1069788. eCollection 2023.
8
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies.延迟钆增强在心肌病中的诊断和预后作用。
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C130-C136. doi: 10.1093/eurheartjsupp/suad015. eCollection 2023 May.
9
Electrocardiographic features and rhythm disorders in cardiac amyloidosis.心脏淀粉样变的心电图特征和节律障碍。
Trends Cardiovasc Med. 2024 May;34(4):257-264. doi: 10.1016/j.tcm.2023.02.006. Epub 2023 Feb 24.
10
Scar conducting channel characterization to predict arrhythmogenicity during ventricular tachycardia ablation.瘢痕传导通道特征分析预测室性心动过速消融期间的心律失常性。
Europace. 2023 Mar 30;25(3):989-999. doi: 10.1093/europace/euac257.